Project Grant K43TW011415

Federal Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded The University of Texas Southwestern Medical Center $451,000 under the Allergy and Infectious Diseases Research program (CFDA 93.855) for a two-year project period (August 1, 2025 – July 31, 2027). This Project Grant supports basic biomedical research investigating how prenatal exposure to maternal helminth (parasitic worm) infections alters immune programming in offspring, with potential...

Federal Grant Award Summary George Washington University received a $242,058 Project Grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), awarded June 5, 2025, with completion expected May 31, 2026. The grant funds planning activities for a Phase 2 clinical trial to evaluate the NA-GST-1 hookworm vaccine candidate using a controlled human infection model (CHIM) paradigm. The primary deliverable is...

Federal Project Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $228,000 Project Grant to Harvard College's T.H. Chan School of Public Health, with performance from April 1, 2026 through March 31, 2028, under the Allergy and Infectious Diseases Research program (CFDA 93.855). This research initiative will investigate the relationship between maternal and infant micronutrient deficiencies—specifically iron, zinc, vitamin A, and vitamin D—and reduced...

Federal Project Grant Award Summary George Washington University received a $444,125 Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) for the period February 3, 2026 through January 31, 2028. The award supports research investigating cross-class selection for anthelmintic resistance in the hookworm Ancylostoma caninum. The research addresses the critical public health challenge of...

Federal Grant Award Summary George Washington University received a $444,125 Project Grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), awarded February 3, 2026, with performance through January 31, 2028. This research project investigates the genetic determinants of host immunity-mediated resistance to helminth infection, specifically focusing on Ascaris species parasites. The research...

Federal Grant Award Summary Seattle Children's Research Institute received a $516,175 Project Grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), awarded on June 23, 2025, with a completion date of May 31, 2027. The award funds research evaluating the impact of pre-existing humoral immunity on hepatocyte death in the context of malaria infection and vaccine efficacy. The research addresses a...

Federal Grant Award Summary Boston University, through its Medical Campus in Roxbury, Massachusetts, received a $2,010,240 Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), effective December 1, 2025, through November 30, 2029. The project will investigate the determinants of poor immune responsiveness to the booster dose of the RTS,S malaria vaccine in African children. The...

Federal Project Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded Cleveland Clinic Lerner College of Medicine of Case Western Reserve University a Project Grant of $1,364,400 under the Allergy and Infectious Diseases Research program (CFDA 93.855), effective August 22, 2025, with completion targeted for July 31, 2030. This prospective observational cohort study will evaluate the impact of early-life malaria and pathogen exposures on the effectiveness...

Federal Grant Award Summary Brigham & Women's Hospital Inc., Department of Faulkner Pathology, received a $194,400 Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), effective September 15, 2025, through August 31, 2029. This research initiative addresses vaccine immunogenicity and immune response in allogeneic hematopoietic stem cell transplant (HCT) recipients, a population...

This $375,000 federal Project Grant award from the National Institute on Drug Abuse (CFDA 93.279 - Drug Use and Addiction Research Programs) aims to evaluate the impact of a status-neutral, person-centric intervention called the "Blue Shed" on HIV transmission and outcomes among people who inject drugs (PWID) in New Delhi, India. The project has three key objectives: Assess the direct impact of the Blue Shed intervention on HIV incidence, viral suppression, and mortality among PWID...